If you liked this article you might like

Bankrupt Introgen Seeks Reincarnation IPO in Biotech Bubble

Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing

The Biotech Bubble Debate: Solid Science vs. Sky-High Valuations

Poof! Biotech's 2014 Outperformance is Gone

Don't Hate Josh Brown For Calling Biotech a Bubble. Learn From Him.